Physician profile
Ralph Cepero
NPI 1952379414
$1,658.74
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.90 · 2020: $141 · 2021: $444 · 2022: $328 · 2023: $449 · 2024: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $436.45 | 2020-2022 | |
| Acclarent, INC | $298.69 | 2019-2024 | Relieva Spinplus, Relieva Scout, Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $211.56 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $190.59 | 2021-2023 | Nucala |
| Genzyme Corporation | $150.08 | 2022-2024 | |
| Olympus America INC. | $143.04 | 2023-2024 | Rhino-Laryngo Videoscope, Diego Elite |
| Smith+Nephew, INC. | $93.72 | 2021-2022 | |
| Medtronic, INC. | $63.24 | 2021-2022 | |
| Innovation Technologies INC | $24.81 | 2023 | Irrisept |
| Novartis Pharmaceuticals Corporation | $18.42 | 2019 | |
| Merck Sharp & Dohme LLC | $15.55 | 2021 | |
| Shire North American Group INC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Cepero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.